| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | SYNRg |
| Uniprot No | Q9UMZ2 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 全长 |
| 氨基酸序列 | full |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于SYNRg重组蛋白的3篇示例文献(注：SYNRg重组蛋白的具体研究方向可能存在差异，以下为虚构示例，建议通过学术数据库核实真实文献)：
---
1. **文献名称**: *"Expression and Functional Analysis of SYNRg Recombinant Protein in Neural Regeneration"*
**作者**: Zhang L, et al.
**摘要**: 研究报道了SYNRg重组蛋白在大肠杆菌中的高效表达与纯化，验证了其在体外促进神经元轴突再生的活性，表明其可能通过激活PI3K/AKT通路发挥作用。
---
2. **文献名称**: *"SYNRg Fusion Protein Enhances Drug Delivery Efficiency in Nanoparticle Systems"*
**作者**: Kim S, et al.
**摘要**: 本文开发了一种基于SYNRg重组蛋白的靶向药物递送系统，通过偶联纳米颗粒显著提高了抗癌药物在肿瘤组织的富集率，并降低了对正常细胞的毒性。
---
3. **文献名称**: *"Structural Characterization and Immunomodulatory Effects of SYNRg Protein"*
**作者**: Gupta R, et al.
**摘要**: 通过X射线晶体学解析了SYNRg重组蛋白的三维结构，并发现其能抑制巨噬细胞炎症因子释放，提示其在治疗自身免疫疾病中的潜在应用价值。
---
如需具体文献，建议在PubMed、Web of Science等平台以“SYNRg recombinant protein”或相关关键词检索。
SYNRg recombinant protein is a engineered protein construct designed for various biomedical and research applications. Derived from the synaptogyrin (SYNGR) family, which comprises integral membrane proteins primarily localized in synaptic vesicles, SYNRg plays a role in modulating synaptic transmission and vesicle trafficking. Synaptogyrins are implicated in neurodevelopmental processes and neurological disorders, making them targets for studying mechanisms underlying conditions like Alzheimer’s disease and schizophrenia. The recombinant form, SYNRg, is typically produced using heterologous gene expression systems (e.g., E. coli, mammalian cells) to ensure high purity and functionality. It retains key structural domains, such as its four transmembrane regions and cytoplasmic termini, critical for interactions with other synaptic proteins like synaptophysin. Researchers utilize SYNRg recombinant protein to investigate vesicle dynamics, membrane fusion, and neurotransmitter release in vitro or in cell-based assays. Its applications extend to antibody production, protein-protein interaction studies, and as a control in diagnostic assays. Additionally, SYNRg serves as a tool for exploring therapeutic strategies targeting synaptic dysfunction. The recombinant format enables scalable production, batch consistency, and customization (e.g., tags for purification or tracking). Ongoing studies aim to clarify its regulatory roles in synaptic plasticity and potential as a biomarker for neural injury or degeneration. By providing a standardized reagent, SYNRg recombinant protein supports advancements in neuroscience and drug discovery pipelines.
×
